Relapsed/Refractory Multiple Myeloma
Relapsed/Refractory Multiple Myeloma is a type of blood cancer that occurs when multiple myeloma returns after treatment or does not respond to therapy, leading to symptoms such as bone pain, fatigue, and anemia.
Multiple Myeloma: Linvoseltamab Therapy Study
We are examining a new treatment called Linvoseltamab for adults with multiple myeloma that hasn't responded to standard care. The study looks at how it works with other cancer treatments.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Universitaire D'Angers
Service Maladies du Sang
Angers, France
Assistance Publique Hopitaux De Paris
Hémopathies Lymphoïdes
Créteil, France
Centre Hospitalier Universitaire De Lille
Département d’hématologie
La Madeleine, France
Sponsor: Regeneron Pharmaceuticals Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.